Literature DB >> 1140849

Differential effects of homocytotropic antibodies on the mast cell and anaphylactic responses in actively and passively sensitized mice.

J B Barnett, D E Justus.   

Abstract

The relationship between mast cell degranulation, anaphylaxis, and the production of homocytotropic antibodies was examined in ICR mice after trichinella infection. It was found that the active cutaneous response to trichinella antigen had a rapid onset (within 2 weeks) and the sensitivity increased over a 9-week period after infection. Two types of mast cell degranulation were observed: (i) moderate, with few extracellular, deep-blue-staining granules (May-Grunwald-Giemsa), and (ii) "explosive," with many extracellular reddish-staining, swollen granules, indicating an apparent breakdown of cell membrane. The moderate type was observed primarily during the first 4 weeks after infection, whereas the explosive type predominated during 5 to 8 weeks. Homocytotropic antibody of the immunoglubulin G(1) type appears responsible for moderate type degranulation, and mouse immunoglobulin E appears responsible for the explosive degranulation. No correlation was evident between the active cutaneous anaphylactic response and either type of degranulation or between active cutaneous anaphylaxis and circulating levels of homocytotropic antibody. A proposed role of immunoglobulin G(1) and mouse immunoglobulin E in immunity is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1140849      PMCID: PMC415221          DOI: 10.1128/iai.11.6.1342-1351.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Passive cutaneous anaphylaxis in the mouse.

Authors:  Z OVARY
Journal:  J Immunol       Date:  1958-10       Impact factor: 5.422

2.  Immediate reactions in the skin of experimental animals provoked by antibody-antigen interaction.

Authors:  Z OVARY
Journal:  Prog Allergy       Date:  1958

3.  The local response of tissue mast cells to antigen in sensitized mice.

Authors:  P B CARTER; R D HIGGINBOTHAM; T F DOUGHERTY
Journal:  J Immunol       Date:  1957-09       Impact factor: 5.422

4.  Mechanism of heparin protection against a histamine releasor.

Authors:  T F DOUGHERTY; R D HIGGINBOTHAM
Journal:  Proc Soc Exp Biol Med       Date:  1956-07

5.  The presence of histamine in tissue mast cells.

Authors:  J F RILEY; G B WEST
Journal:  J Physiol       Date:  1953-06-29       Impact factor: 5.182

6.  Release of 5-hydroxytryptamine from mouse peritoneal mast cells during active and passive anaphylactic reactions.

Authors:  A Prouvost-Danon; J M Peixoto; M Q Javierre
Journal:  Life Sci       Date:  1966-10       Impact factor: 5.037

7.  Trichinella spiralis: immunologic response to infection in mice.

Authors:  R B Crandall; C A Crandall
Journal:  Exp Parasitol       Date:  1972-06       Impact factor: 2.011

8.  Selective release of histamine from rat mast cells by compound 48-80 and anitgen.

Authors:  A R Johnson; N C Moran
Journal:  Am J Physiol       Date:  1969-03

9.  Antigen-indued histamine release from peritoneal mast cells of mice producing reagin-like antibody.

Authors:  A Prouvost-Danon; J M Peixoto; M Q Javierre
Journal:  Immunology       Date:  1968-08       Impact factor: 7.397

10.  The significance of circulating IgE. Correlation of amount of circulating reaginic antibody with cutaneous sensitivity in the rat.

Authors:  E E Jarrett; D C Stewart
Journal:  Immunology       Date:  1973-01       Impact factor: 7.397

View more
  2 in total

1.  Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea-pigs: inhibition of IgE-but not of IgG-mediated anaphylaxis.

Authors:  P Andersson; R Brattsand
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

2.  Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs: effect of long-term treatment with sodium cromoglycate and aminophylline.

Authors:  P Andersson; H Bergstrand
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.